The Billion Dollar Patent

Source: DailyBruin

10/01/2020

 

Nearly 8,000 miles from the polished offices of Murphy Hall sits a black stone slab the size of Chancellor Gene Block’s office bookshelf.

Maroon, white and orange flowers dress the upper surface in ornate polygonal patterns. A bronze lamp stands at the slab’s head, a small flame burning inside the rectangular glass casing. Pristine green grass surrounds the site and sandstone-colored tiles snake around the exterior to form a walking path.

Continue reading

Posted in Patents | Leave a comment

On Announcement of All Oral MDR TB regimen by Indian Government

26th Sep 2019, New Delhi

On 25 September Wednesday, at the event- TB Harega Desh Jitega organised in New Delhi, the Central TB programme announced the rolling out an all oral Multi Drug Resistant TB regimen across the country starting with four states, based on one of the two new drugs – Bedaquiline or Delamanid – replacing injectable in the treatment regimen.

While the announcement is a welcome step from the Indian government, in a context like India with high prevalence of fluoroquinolones resistance, many DR-TB patients would require both Bedaquilin and Delamanid in the treatment regimen. Without such access, all oral regimen for Pre-XDR and XDR patients will not become a reality.

The issue has already been raised by Indian civil society including TB survivors and activists by a letter in Dec 2018, demanding scale-up for Bedaquilin and Delamanid. The letter can be read here.

Posted in Access to Medecines, Drugs, Multi-Drug Resistant Bacteria | Leave a comment

Modi visit to US: Trump appearance signals importance of India

Source: BBC News

22nd September 2019

 

Modi and Trump

Five years ago, when Narendra Modi first stepped on US soil as India’s prime minister to chants of his name and “Hail Mother India”, many called it audacious.

The rock star reception at New York’s Madison Square Garden resembled a victory lap for a leader who had been denied entry into the US for almost a decade.

Continue reading

Posted in Trade Agreements, US-India FTA | Leave a comment

After ‘Howdy Modi’, Trump and Modi likely to sign trade deal

Source: Live Mint

22nd September 2019

 

  • The deal will lower some tariffs on US produce and restore preferential treatment for some Indian exports to the United States
  • US President Donald Trump and Prime Minister Narendra will meet this Sunday in Houston

Washington/New Delhi: The United States and India are racing to negotiate a limited trade deal that US President Donald Trump and Indian Prime Minister Narendra Modi can sign at the United Nations General Assembly in New York at the end of September, people familiar with the talks said.

Continue reading

Posted in Trade Agreements, US-India FTA | Leave a comment

US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?

Source: International Business Times

22nd September 2019

 

resident Donald Trump is set to meet Indian Prime Minister Modi on Sunday at an Indian-American rally in Houston called “Howdy Modi!” Although both nations are engaged in a tense tariff battle, some believe the two leaders could hash out a trade deal by the end of the month when both attend the United Nations General Assembly on Tuesday.

Continue reading

Posted in Trade Agreements, US-India FTA | Leave a comment

India-US trade talks: Trading lives?

Source: Deccan Herald

21st September 2019

Prime Minister Narendra Modi is set to meet US President Donald Trump to discuss trade issues between the two countries in a few days’ time. Health workers and doctors working with patients suffering from tuberculosis, HIV/AIDS, cancer, those needing artificial prosthesis like stents, etc., are worried that the trade decisions may hurt patients as they may not be able to get access to many life-saving medicines. This is a matter of importance not just for India, but for most of the world. Health workers and doctors not just in India but those in other developing countries are eagerly watching the outcome of these trade discussions. Will the trade negotiations end up trading away lives?

Continue reading

Posted in IP Rights, Trade Agreements, US-India FTA | Leave a comment

As Modi Visits US, What Does the Free Trade Pact Mean for India’s Pharma Industry?

Source: The Wire

21st September 2019

A Free Trade Agreement with the US will likely result in the amendment of the Patents Act, which could impact the Indian pharma industry. 

As Modi Visits US, What Does the Free Trade Pact Mean for India's Pharma Industry?

Prime Minister Narendra Modi is scheduled to travel to the US on Saturday to attend the annual United Nations General Assembly in New York and will address the high-level general assembly session on September 27. The Indian prime minister is also expected to have several high-level bilateral and multilateral engagements on the sidelines of the UN meeting. Among all his engagements, the one with US President Donald Trump is the most keenly-awaited.

Continue reading

Posted in FTA, Trade Agreements, US-India FTA | Leave a comment